Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Federal authorities are taking a closer look at Allergan’s ongoing battle to keep unrequited acquirer Valeant Pharmaceuticals at bay.
Allergan announced this week that the Federal Trade Commission issued a “Second Request” for additional information about Valeant’s offer, which Allergan has been batting back for months. Read more
A federal judge last week let stand most of the claims alleged by Zimmer in a lawsuit accusing Stryker and a former sales rep of scheming to insert a “Trojan horse” into Zimmer’s Texas sales operation.
The lawsuit, filed last January in the U.S. District Court for Northern Indiana against Stryker and an ex-Zimmer rep named Cory Stovall, alleges that Stryker agreed to pay Stovall a bounty for every Zimmer customer he converts to Stryker. Read more
Medtech titan Medtronic has a few heavy-hitters in its corner during its fight against anti-corporate inversion measures on Capitol Hill.
Regulatory disclosures show that Medtronic hired a lobbying group that includes Trent Lott, former Senate Majority Leader, and John Breaux, former member of the Senate Finance Committee. Medtronic’s reports indicate that the duo will devote its lobbying effort to “issues regarding acquisition of medical supplies provider Covidien.” Read more